Structural lung changes, lung function, and non-invasive inflammatory markers in cystic fibrosis

Pediatric Allergy and Immunology

Volumn 21, Issue 3, 2010, Pages 493-500

  Robroeks, Charlotte M H H T ^a   Roozeboom, Marieke H ^a   De Jong, Pim A ^b   Tiddens, Harm A W M ^c   Jöbsis, Quirijn ^a   Hendriks, Han J ^a   Yntema, Jan Bart L ^d   Brackel, Hein L ^e   Van Gent, Rene ^f   Robben, Simon ^a   Dompeling, Edward ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

^f MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

Cystic fibrosis; Exhaled breath condensate; High resolution computed tomography; Lung changes; Lung function; Non invasive inflammatory markers

Indexed keywords

8 ISOPROSTANE; GAMMA INTERFERON; HYDROGEN PEROXIDE; NITRATE; NITRIC OXIDE; NITRITE; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM CULTURE; BRONCHIECTASIS; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFANT; LUNG DEVELOPMENT; LUNG FIBROSIS; LUNG FUNCTION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS; SCHOOL CHILD; TOTAL LUNG CAPACITY; CYSTIC FIBROSIS; EXHALATION; INFLAMMATION; LUNG; LUNG FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CYSTIC FIBROSIS; EXHALATION; FEMALE; HUMANS; INFLAMMATION; LUNG; MALE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951711309     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2009.00872.x     Document Type: Article

References (44)

1. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995 : 151 : 1075 1082.
2. Hartl D, Griese M, Kappler M, et al. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol 2006 : 117 : 204 211. (Pubitemid 43017162)
3. Koller DY, Nething I, Otto J, Urbanek R, Eichler I. Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity. Am J Respir Crit Care Med 1997 : 155 : 1050 1054. (Pubitemid 27133422)
4. Linnane SJ, Keatings VM, Costello CM, et al. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 1998 : 158 : 207 212.
5. Cetin I, Ozcelik U, Gocmen A, Kiper N, Dogru D, Yalcin E. BALF nitrite as an indicator of inflammation in children with cystic fibrosis. Respiration 2004 : 71 : 625 629. (Pubitemid 40091436)
6. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 2003 : 167 : 1109 1112. (Pubitemid 36459657)
7. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006 : 130 : 1541 1546.
8. Robroeks CMHHT, Jöbsis Q, Damoiseaux JGMC, et al. Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis. Ann Allergy Asthma Immunol 2006 : 96 : 349 355. (Pubitemid 43277176)
9. Carpagnano GE, Barnes PJ, Francis J, Wilson N, Bush A, Kharitonov SA. Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? Chest 2004 : 125 : 2005 2010. (Pubitemid 38788163)
10. Rahman I, Kelly F. Biomarkers in breath condensate: a promising new non-invasive technique in free radical research. Free Radic Res 2003 : 37 : 1253 1266. (Pubitemid 37441709)
11. Rosias P, Den Hartog G, Robroeks C, et al. Free radicals in exhaled breath condensate in cystic fibrosis and healthy subjects. Free Radic Res 2006 : 40 : 901 909. (Pubitemid 44480552)
12. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000 : 55 : 205 209. (Pubitemid 30245970)
13. Ho LP, Innes JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998 : 53 : 680 684.
14. Formanek W, Inci D, Lauener RP, Wildhaber JH, Frey U, Hall GL. Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J 2002 : 19 : 487 491. (Pubitemid 34256964)
15. Thomas SR, Kharitonov SA, Scott SF, Hodson ME, Barnes PJ. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 2000 : 117 : 1085 1089.
16. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004 : 145 : 32 8. (Pubitemid 38962449)
17. Grasemann H, Michler E, Wallot M, Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 1997 : 24 : 173 177. (Pubitemid 27431226)
18. Brody AS, Molina PL, Klein JS, Rothman BS, Ramagopal M, Swartz DR. High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 1999 : 29 : 731 735. (Pubitemid 29450139)
19. Helbich TH, Heinz-Peer G, Eichler I, et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology 1999 : 213 : 537 544. (Pubitemid 29510604)
20. de Jong PA, Nakano Y, Lequin MH, et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004 : 23 : 93 7. (Pubitemid 38088503)
21. Maffessanti M, Candusso M, Brizzi F, Piovesana F. Cystic fibrosis in children: HRCT findings and distribution of disease. J Thorac Imaging 1996 : 11 : 27 38. (Pubitemid 126443567)
22. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991 : 179 : 783 788.
23. Tiddens HA, de Jong PA. Update on the application of chest computed tomography scanning to cystic fibrosis. Curr Opin Pulm Med 2006 : 12 : 433 439. (Pubitemid 44624604)
24. Tiddens HA. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002 : 34 : 228 231. (Pubitemid 34971078)
25. Judge EP, Dodd JD, Masterson JB, Gallagher CG. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest 2006 : 130 : 1424 1432.
26. Robinson TE. High-resolution CT scanning: potential outcome measure. Curr Opin Pulm Med 2004 : 10 : 537 541. (Pubitemid 39441450)
27. de Jong PA, Ottink MD, Robben SG, et al. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 2004 : 231 : 434 439.
28. Davis SD, Fordham LA, Brody AS, et al. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 2007 : 175 : 943 950.
29. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003 : 168 : 918 951. (Pubitemid 37267172)
30. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003 : 361 : 681 689. (Pubitemid 36246556)
31. Guran T, Ersu R, Karadag B, et al. Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis. Pediatr Pulmonol 2007 : 42 : 362 369. (Pubitemid 46608906)
32. Gerver W, de Bruin R. Paediatric morphometrics. A Reference Manual. 2nd extended edn.
33. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998 : 132 : 589 595.
34. Brody AS, Kosorok MR, Li Z, et al. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 2006 : 21 : 14 21.
35. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J Respir Crit Care Med 2005 : 171 : 912 930.
36. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993 : 214 : 11 6. (Pubitemid 23300346)
37. Hilliard TN, Regamey N, Shute JK, et al. Airway remodelling in children with cystic fibrosis. Thorax 2007 : 62 : 1074 1080. (Pubitemid 350206200)
38. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005 : 26 : 319 338. (Pubitemid 41079078)
39. Dales RE, Spitzer WO, Tousignant P, Schechter M, Suissa S. Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis 1988 : 138 : 317 320.
40. Dakin CJ, Pereira JK, Henry RL, Wang H, Morton JR. Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis. Pediatr Pulmonol 2002 : 33 : 475 482. (Pubitemid 34547869)
41. Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995 : 29 : 777 807. (Pubitemid 26005359)
42. Ferrari M, Cremonesi L. Genotype-phenotype correlation in cystic fibrosis patients. Ann Biol Clin (Paris) 1996 : 54 : 235 241. (Pubitemid 26294402)
43. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996 : 75 : 319 322. (Pubitemid 26354603)
44. Gaston B, Ratjen F, Vaughan JW, et al. Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am J Respir Crit Care Med 2002 : 165 : 387 390. (Pubitemid 34118514)